Personalized Management of Chemotherapy-Induced Peripheral Neuropathy Based on a Patient Reported Outcome: CALGB 40502 (Alliance).

Personalized Management of Chemotherapy-Induced Peripheral Neuropathy Based on a Patient Reported Outcome: CALGB 40502 (Alliance). J Clin Pharmacol. 2020 04; 60(4):444-452.

View in: PubMed

subject areas

Albumins
Algorithms
Antineoplastic Agents
Antineoplastic Combined Chemotherapy Protocols
Breast Neoplasms
Computer Simulation
Drug Administration Schedule
Epothilones
Female
Humans
Models, Biological
Paclitaxel
Patient Reported Outcome Measures
Peripheral Nervous System Diseases
Precision Medicine

authors with profiles

Mark J. Ratain